For example, various mutations in the cell surface receptor domain or the cytoplasmic kinase domain constitutively activate RET in about 95% of hereditary MTC and about 50% of sporadic MTC cases (reviewed in [7,8]). This evidence concerns the gene RET and medullary thyroid gland carcinoma.